169 related articles for article (PubMed ID: 20499410)
1. Glioma pathogenesis-related protein 1: tumor-suppressor activities and therapeutic potential.
Thompson TC
Yonsei Med J; 2010 Jul; 51(4):479-83. PubMed ID: 20499410
[TBL] [Abstract][Full Text] [Related]
2. Glioma pathogenesis-related protein 1 exerts tumor suppressor activities through proapoptotic reactive oxygen species-c-Jun-NH2 kinase signaling.
Li L; Abdel Fattah E; Cao G; Ren C; Yang G; Goltsov AA; Chinault AC; Cai WW; Timme TL; Thompson TC
Cancer Res; 2008 Jan; 68(2):434-43. PubMed ID: 18199537
[TBL] [Abstract][Full Text] [Related]
3. Tumor growth and metastasis suppression by Glipr1 gene-modified macrophages in a metastatic prostate cancer model.
Tabata K; Kurosaka S; Watanabe M; Edamura K; Satoh T; Yang G; Abdelfattah E; Wang J; Goltsov A; Floryk D; Thompson TC
Gene Ther; 2011 Oct; 18(10):969-78. PubMed ID: 21512508
[TBL] [Abstract][Full Text] [Related]
4. Systemic GLIPR1-ΔTM protein as a novel therapeutic approach for prostate cancer.
Karantanos T; Tanimoto R; Edamura K; Hirayama T; Yang G; Golstov AA; Wang J; Kurosaka S; Park S; Thompson TC
Int J Cancer; 2014 Apr; 134(8):2003-13. PubMed ID: 24590455
[TBL] [Abstract][Full Text] [Related]
5. Glioma pathogenesis-related protein 1 performs dual functions in tumor cells.
Wang J; Li Z; Yin F; Zhang R; Zhang Y; Wang Z; Sheng X
Cancer Gene Ther; 2022 Mar; 29(3-4):253-263. PubMed ID: 33742130
[TBL] [Abstract][Full Text] [Related]
6. GLIPR1 tumor suppressor gene expressed by adenoviral vector as neoadjuvant intraprostatic injection for localized intermediate or high-risk prostate cancer preceding radical prostatectomy.
Sonpavde G; Thompson TC; Jain RK; Ayala GE; Kurosaka S; Edamura K; Tabata K; Ren C; Goltsov AA; Mims MP; Hayes TG; Ittmann MM; Wheeler TM; Gee A; Miles BJ; Kadmon D
Clin Cancer Res; 2011 Nov; 17(22):7174-82. PubMed ID: 21933889
[TBL] [Abstract][Full Text] [Related]
7. Combined therapeutic effects of adenoviral vector-mediated GLIPR1 gene therapy and radiotherapy in prostate and bladder cancer models.
Fujita T; Satoh T; Timme TL; Hirayama T; Zhu JX; Kusaka N; Naruishi K; Yang G; Goltsov A; Wang J; Vlachaki MT; Teh BS; Brian Butler E; Thompson TC
Urol Oncol; 2014 Feb; 32(2):92-100. PubMed ID: 23433894
[TBL] [Abstract][Full Text] [Related]
8. GLIPR1 suppresses prostate cancer development through targeted oncoprotein destruction.
Li L; Ren C; Yang G; Fattah EA; Goltsov AA; Kim SM; Lee JS; Park S; Demayo FJ; Ittmann MM; Troncoso P; Thompson TC
Cancer Res; 2011 Dec; 71(24):7694-704. PubMed ID: 22025562
[TBL] [Abstract][Full Text] [Related]
9. GLI pathogenesis-related 1 functions as a tumor-suppressor in lung cancer.
Sheng X; Bowen N; Wang Z
Mol Cancer; 2016 Mar; 15():25. PubMed ID: 26988096
[TBL] [Abstract][Full Text] [Related]
10. TPX2-p53-GLIPR1 regulatory circuitry in cell proliferation, invasion, and tumor growth of bladder cancer.
Yan L; Li Q; Yang J; Qiao B
J Cell Biochem; 2018 Feb; 119(2):1791-1803. PubMed ID: 28799673
[TBL] [Abstract][Full Text] [Related]
11. Glioma pathogenesis-related protein 1 induces prostate cancer cell death through Hsc70-mediated suppression of AURKA and TPX2.
Li L; Yang G; Ren C; Tanimoto R; Hirayama T; Wang J; Hawke D; Kim SM; Lee JS; Goltsov AA; Park S; Ittmann MM; Troncoso P; Thompson TC
Mol Oncol; 2013 Jun; 7(3):484-96. PubMed ID: 23333597
[TBL] [Abstract][Full Text] [Related]
12. GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells.
Karanika S; Karantanos T; Kurosaka S; Wang J; Hirayama T; Yang G; Park S; Golstov AA; Tanimoto R; Li L; Thompson TC
Mol Cancer; 2015 Jun; 14():122. PubMed ID: 26084402
[TBL] [Abstract][Full Text] [Related]
13. Adenoviral vector-mediated mRTVP-1 gene therapy for prostate cancer.
Satoh T; Timme TL; Saika T; Ebara S; Yang G; Wang J; Ren C; Kusaka N; Mouraviev V; Thompson TC
Hum Gene Ther; 2003 Jan; 14(2):91-101. PubMed ID: 12614561
[TBL] [Abstract][Full Text] [Related]
14. Hypomethylation and aberrant expression of the glioma pathogenesis-related 1 gene in Wilms tumors.
Chilukamarri L; Hancock AL; Malik S; Zabkiewicz J; Baker JA; Greenhough A; Dallosso AR; Huang TH; Royer-Pokora B; Brown KW; Malik K
Neoplasia; 2007 Nov; 9(11):970-8. PubMed ID: 18030365
[TBL] [Abstract][Full Text] [Related]
15. GLIPR1 expression is reduced in multiple myeloma but is not a tumour suppressor in mice.
Friend N; Noll JE; Opperman KS; Clark KC; Mrozik KM; Vandyke K; Hewett DR; Zannettino ACW
PLoS One; 2020; 15(1):e0228408. PubMed ID: 31995627
[TBL] [Abstract][Full Text] [Related]
16. Combined therapy of CAR-IL-15/IL-15Rα-T cells and GLIPR1 knockdown in cancer cells enhanced anti-tumor effect against gastric cancer.
Ye J; Liu Q; He Y; Song Z; Lin B; Hu Z; Hu J; Ning Y; Cai C; Li Y
J Transl Med; 2024 Feb; 22(1):171. PubMed ID: 38368374
[TBL] [Abstract][Full Text] [Related]
17. Identification of GLIPR1 tumor suppressor as methylation-silenced gene in acute myeloid leukemia by microarray analysis.
Xiao YH; Li XH; Tan T; Liang T; Yi H; Li MY; Zeng GQ; Wan XX; Qu JQ; He QY; Li JH; Chen Y; Xiao ZQ
J Cancer Res Clin Oncol; 2011 Dec; 137(12):1831-40. PubMed ID: 21922325
[TBL] [Abstract][Full Text] [Related]
18. Expression, purification, crystallization and preliminary X-ray analysis of a truncated soluble domain of human glioma pathogenesis-related protein 1.
Bonafé N; Zhan B; Bottazzi ME; Perez OA; Koski RA; Asojo OA
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Nov; 66(Pt 11):1487-9. PubMed ID: 21045302
[TBL] [Abstract][Full Text] [Related]
19. GliPR1 knockdown by RNA interference exerts anti-glioma effects in vitro and in vivo.
Scheuring UJ; Ritter S; Martin D; Schackert G; Temme A; Tietze S
J Neurooncol; 2021 May; 153(1):23-32. PubMed ID: 33856615
[TBL] [Abstract][Full Text] [Related]
20. GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin.
Gong X; Liu J; Zhang D; Yang D; Min Z; Wen X; Wang G; Li H; Song Y; Bai C; Li J; Zhou J
PLoS One; 2017; 12(8):e0182410. PubMed ID: 28771580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
